Challenges and Solutions in the Management of Multiple Sclerosis
A panel of experts in neurology discuss comorbidities in multiple sclerosis and the use of sphingosine 1-phosphate receptor modulators for treatment. They discuss data on sequencing of disease modifying therapies and challenges and their approaches to guiding patients through treatment discontinuations.
EP. 2: Differences Between MS Patient Characteristics in Clinical Trials and Real-World Populations
November 22nd 2022Stephen Krieger, MD; Daniel Bandari, MD, MS; Bruce Hughes, MD; Mitzi Williams, MD; and Heidi Crayton, MD, review the OPTIMISE study and reflect on the differences between patient characteristics in clinical trial settings vs clinical practice.
EP. 4: S1P Receptor Modulator Treatment in Female Patients with MS
November 29th 2022Stephen Krieger, MD; Daniel Bandari, MD, MS; Bruce Hughes, MD; Mitzi Williams, MD; and Heidi Crayton, MD, review data on ponesimod vs teriflunomide for the treatment of female patients with multiple sclerosis who are of childbearing age.
EP. 6: Long-Term Safety of S1P Receptor Modulators in Multiple Sclerosis
December 6th 2022Stephen Krieger, MD; Daniel Bandari, MD, MS; Bruce Hughes, MD; Mitzi Williams, MD; and Heidi Crayton, MD, examine the safety of sphingosine 1-phosphate receptor modulators for the treatment of multiple sclerosis.
EP. 7: Sequencing Disease-Modifying Therapies in Multiple Sclerosis
December 13th 2022Stephen Krieger, MD; Daniel Bandari, MD, MS; Bruce Hughes, MD; Mitzi Williams, MD; and Heidi Crayton, MD, share their thoughts on sequencing disease-modifying therapies when treating patients with multiple sclerosis.
EP. 8: Switching Therapies for Patients with Multiple Sclerosis
December 13th 2022Stephen Krieger, MD; Daniel Bandari, MD, MS; Bruce Hughes, MD; Mitzi Williams, MD; and Heidi Crayton, MD, discuss their approach to switching treatments for patients with multiple sclerosis and the timing between therapies.
